Improving Provider Counseling Interventions in HIV Practice
The recruitment status of this study is unknown because the information has not been verified recently.
Verified September 2007 by Johns Hopkins University.
Recruitment status was Active, not recruiting
Recruitment status was Active, not recruiting
Sponsor:
Johns Hopkins University
Collaborator:
University of California, San Francisco
Information provided by:
Johns Hopkins University
ClinicalTrials.gov Identifier:
NCT00538993
First received: October 1, 2007
Last updated: NA
Last verified: September 2007
History: No changes posted
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Hypothesis: HIV clinicians trained to deliver brief counseling messages and receiving cues from a brief computer survey on risk behaviors of their patients can counsel have an impact on patient's risk behaviors.
| Condition | Intervention |
|---|---|
|
HIV Infections |
Behavioral: Stage based counseling |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Health Services Research |
Resource links provided by NLM:
Further study details as provided by Johns Hopkins University:
Primary Outcome Measures:
- Disclosure of HIV status to sex partners; unprotected sexual encounters. [ Time Frame: 12 months ]
| Estimated Enrollment: | 425 |
| Study Start Date: | September 2003 |
| Estimated Study Completion Date: | October 2007 |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: 1
Provider receives cue sheet to assist with counseling.
|
Behavioral: Stage based counseling |
|
No Intervention: 2
Provider does not receive cue sheet.
|
Detailed Description:
This is a randomized controlled study. The purpose of this study is to assess the impact of the cue sheet as an aid to targeted provider behavioral counseling. All enrolled participants are HIV+ adults seen for regular medical care at a site affiliated with the Johns Hopkins AIDS Service. After consenting, participants will take an audio-assisted computer interviews to collect patient risk assessment data. For participants randomized to the intervention arm, the printed output on risk behaviors is then given to the provider along with cues for staged-based counseling for use during the same visit. Participants in the control arm take the same computerized risk assessment but there are no printed cue sheets. Risk behaviors of all participants are assessed at entry, at 6 months, and at 12 months. The main outcome measure is change in HIV transmission behaviors at 12 months for those in the intervention arm compared to the control arm.
Eligibility| Ages Eligible for Study: | 18 Years and older (Adult, Senior) |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- HIV seropositive
- English speaking
Exclusion Criteria:
- Cannot give informed consent
Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00538993
Please refer to this study by its ClinicalTrials.gov identifier: NCT00538993
Locations
| United States, Maryland | |
| Johns Hopkins University School of Medicine | |
| Baltimore, Maryland, United States, 21205 | |
Sponsors and Collaborators
Johns Hopkins University
University of California, San Francisco
Investigators
| Principal Investigator: | Emily Erbelding, M.D. | Johns Hopkins University |
More Information
| ClinicalTrials.gov Identifier: | NCT00538993 History of Changes |
| Other Study ID Numbers: | H97HA01144 |
| Study First Received: | October 1, 2007 |
| Last Updated: | October 1, 2007 |
| Health Authority: | United States: Federal Government |
Additional relevant MeSH terms:
|
HIV Infections Lentivirus Infections Retroviridae Infections RNA Virus Infections Virus Diseases |
Sexually Transmitted Diseases, Viral Sexually Transmitted Diseases Immunologic Deficiency Syndromes Immune System Diseases |
ClinicalTrials.gov processed this record on September 23, 2016